Jingmin Ji

No. 3 Xingyuan Road
Shijiazhuang, 050200, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Evolution and textual quantitative analysis of China's palliative care policies: a three-dimensional analytical framework approach.

Evolution and textual quantitative analysis of China's palliative care policies: a three-dimensional analytical framework approach.

Journal: Frontiers in public health

Published: May 07, 2025

A qualitative study on the experience of internet outpatient consultation in palliative care for relatives of cancer patients.

A qualitative study on the experience of internet outpatient consultation in palliative care for relatives of cancer patients.

Journal: BMC palliative care

Published: November 02, 2024

Hepatocyte-Specific Yap1 Knockout Maintained the Liver Homeostasis of Lipid Metabolism in Mice.

Hepatocyte-Specific Yap1 Knockout Maintained the Liver Homeostasis of Lipid Metabolism in Mice.

Journal: Diabetes, metabolic syndrome and obesity : targets and therapy

Published: June 12, 2024

Dihydroartemisinin increased the abundance of Akkermansia muciniphila by YAP1 depression that sensitizes hepatocellular carcinoma to anti-PD-1 immunotherapy.

Dihydroartemisinin increased the abundance of Akkermansia muciniphila by YAP1 depression that sensitizes hepatocellular carcinoma to anti-PD-1 immunotherapy.

Journal: Frontiers of medicine

Published: October 07, 2022

Si-Ni-San reduces lipid droplet deposition associated with decreased YAP1 in metabolic dysfunction-associated fatty liver disease.

Si-Ni-San reduces lipid droplet deposition associated with decreased YAP1 in metabolic dysfunction-associated fatty liver disease.

Journal: Journal of ethnopharmacology

Published: September 27, 2022

Dihydroartemisinin broke the tumor immunosuppressive microenvironment by inhibiting YAP1 expression to enhance anti-PD-1 efficacy.

Dihydroartemisinin broke the tumor immunosuppressive microenvironment by inhibiting YAP1 expression to enhance anti-PD-1 efficacy.

Journal: Phytotherapy research : PTR

Published: April 15, 2022

Dihydroartemisinin inhibited the Warburg effect through YAP1/SLC2A1 pathway in hepatocellular carcinoma.

Dihydroartemisinin inhibited the Warburg effect through YAP1/SLC2A1 pathway in hepatocellular carcinoma.

Journal: Journal of natural medicines

Published: October 04, 2021

Modulation of Oral Microflora during Helicobacter Pylori Eradication.

Modulation of Oral Microflora during Helicobacter Pylori Eradication.

Journal: Journal of the College of Physicians and Surgeons--Pakistan : JCPSP

Published: August 11, 2021

Dihydroartemisinin reduced lipid droplet deposition by YAP1 to promote the anti-PD-1 effect in hepatocellular carcinoma.

Dihydroartemisinin reduced lipid droplet deposition by YAP1 to promote the anti-PD-1 effect in hepatocellular carcinoma.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: July 18, 2021

The Effects of Qinghao-Kushen and Its Active Compounds on the Biological Characteristics of Liver Cancer Cells.

The Effects of Qinghao-Kushen and Its Active Compounds on the Biological Characteristics of Liver Cancer Cells.

Journal: Evidence-based complementary and alternative medicine : eCAM

Published: July 17, 2021

Anti-malarial drug dihydroartemisinin downregulates the expression levels of CDK1 and CCNB1 in liver cancer.

Anti-malarial drug dihydroartemisinin downregulates the expression levels of CDK1 and CCNB1 in liver cancer.

Journal: Oncology letters

Published: March 17, 2021

Cisplatin promotes the expression level of PD-L1 in the microenvironment of hepatocellular carcinoma through YAP1.

Cisplatin promotes the expression level of PD-L1 in the microenvironment of hepatocellular carcinoma through YAP1.

Journal: Molecular and cellular biochemistry

Published: March 06, 2020

Showing 1-12 of 12

Last Updated: 09/26/2026